Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
OHSU Knight Cancer Institute
With
Oregon Health and Science University
ATS Foundation
Hildegard Lamfrom Endowment
Medical Research Foundation, Oregon
PRIMARY OBJECTIVES:
I. Refine a conversation tool among patients with lung cancer by conducting prototype testing in an iterative process.
II. Conduct a trial at two comprehensive cancer treatment centers representing academic and Veterans Affairs medical centers.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM I: Patients receive the conversation tool.
ARM II: Patients receive usual care.
Patients in both arms are followed up within 4-8 weeks after baseline to complete a second questionnaire.
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
PART I: Completed treatment for suspected or confirmed stage I-IV non-small cell lung cancer (NSCLC)
PART I: English fluency
PART II: Undergoing diagnostic work-up for suspected stage I-IV NSCLC
PART II: English fluency
PART II: \> 6-month life expectancy
PART II: Score of \> 3 on the 6-Item Screener for Cognitive Impairment